Creyos

Digital Cognitive Assessment Softwarecreyos.com

Company typePrivate
Founded2014
HeadquartersToronto, Canada
Headcount51–100
GTM typeB2B
OfferingSoftware

Creyos firmographics

Firmographics

Name: Creyos
Legal name: Cambridge Brain Sciences Inc.
Website: https://creyos.com
Company type: Private
Founded year: 2014
Operating status: Operating
Headcount range: 51–100 employees
Ownership category
akta.pro rank

Creyos industry classification

Industry

Product category: Digital Cognitive Assessment Software
NAICS: Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (5182), Custom Computer Programming Services (541511)
SIC: Services-Prepackaged Software (7372)
akta.pro primary industry: Patient Relationship Management (PRM) & CRM for Provider Growth (Marketing/Outreach) (HLACAEAO)

Keywords

Cognitive assessment software
Digital health platform
Behavioral health questionnaires
Clinical decision support
Brain health evaluation

Where Creyos is headquartered

Location

Headquarters

HQ city: Toronto
HQ country: Canada
HQ region: North America

Offices2 records

Markets served

Creyos business model

Business model

GTM type: B2B
Offering type: Software
Cost components: Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

Cognitive Assessment Platform Subscription: Creyos operates on a subscription basis providing access to its cognitive assessment platform, including cognitive tasks, behavioral questionnaires, protocols, and reporting. The platform is used by healthcare providers and can be reimbursed as part of Medicaid services and Medicare Annual Wellness Visits.

Pricing tiers

Model	Billing	Price
Subscription	Annual	Enterprise/Healthcare Organization Pricing

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Creyos product offering

Product offering

Core offering

Creyos provides a digital cognitive assessment platform that delivers scientifically validated online cognitive tasks and standardized behavioral health questionnaires for healthcare providers. The platform includes 12 cognitive tasks measuring domains such as short-term memory, reasoning, concentration, and verbal ability, alongside condition-focused assessment protocols for ADHD and dementia, automated reporting, and direct EHR integration with Epic and Athenahealth. It is used by 10,000+ healthcare providers to evaluate brain health across conditions including dementia, ADHD, concussion, and traumatic brain injury.

Product overview

Creyos offers a digital cognitive assessment platform built on over 30 years of scientific research, consisting of a core platform with multiple integrated modules. The core platform provides 12 online cognitive tasks measuring specific brain functions (short-term memory, reasoning, concentration, verbal ability) and standardized behavioral health questionnaires. Supporting modules include condition-focused assessment protocols for ADHD and dementia, a rapid two-task digital cognitive screener for dementia detection, Care Planning for dementia management aligned to Alzheimer's Association guidelines, and automated reporting with EHR integration. The platform serves medical practices, health systems, payers, and researchers across neurology, psychiatry, occupational therapy, concussion/brain injury, primary care, and senior-focused care.

Differentiator

Problem solved

Functional benefit

Products and services

Creyos Cognitive Assessment Platform Digital cognitive assessment platform providing scientifically-validated cognitive testing and behavioral health questionnaires for healthcare providers to evaluate brain health across conditions including dementia, ADHD, concussion, and traumatic brain injury.
Online Cognitive Tasks Twelve computerized cognitive tests measuring specific cognitive domains including short-term memory (Number Ladder, Spatial Span, Paired Associates, Token Search), reasoning (Odd One Out, Spatial Planning, Rotations, Polygons), concentration (Double Trouble, Feature Match), and verbal ability (Digit Span, Grammatical Reasoning).
Behavioral Health Questionnaires Digital standardized questionnaires covering mental health (PHQ-9, GAD-7, PSS, MDQ, PCL-5), ADHD and autism (SWAN, VADRS, ASRS Part A, AQ), substance misuse (AUDIT, ORT, DAST-10, PMQ), and brain injury/disturbances (RPQ, IADL, PSQI).
Condition-Focused Assessment Protocols Pre-made, condition-specific cognitive assessment protocols including ADHD Assessment and Dementia Screening and Assessment, designed for timely clinical decision-making with pre-selected tasks and questionnaires.
Dementia Screening and Assessment End-to-end solution for cognitive screening, assessment, and care including a rapid two-task screener (under 5 minutes), comprehensive 20-minute diagnostic assessment, care planning, and longitudinal monitoring for mild cognitive impairment and dementia.
ADHD Assessment Protocol Scientifically-validated cognitive assessment protocol testing cognitive domains linked to ADHD, measuring performance against 14 specific ADHD markers with age-appropriate questionnaire options (ASRS Part A, SWAN, VADRS).
Cognitive Reports Automated reporting system generating concise reports comparing patient performance against healthy norms, providing clear next steps and care planning guidance for healthcare providers.
Care Planning Dementia care planning feature integrated into the platform, enabling primary care providers to create personalized care plans addressing medication, lifestyle changes, risk factors, and caregiver support, aligned to Alzheimer's Association guidelines.

Quantifiable outcome

Two-task screener achieved 100% sensitivity and 86% specificity for Alzheimer's disease detection in approximately 6 minutes without clinical supervision
+3 more outcomes

Companies that use Creyos

Customer profile

Named customers5 records

Segments6 records

Ideal customer profiles6 records

Creyos technology and API

Technology

Technology focussed Yes

API detail

Has API: Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability3 records

Feature6 records

Creyos partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and major.

Epic SystemscoreTechnology or Integration · 20 May 2026Creyos is expanding integration capabilities to directly connect with Epic EHR, embedding cognitive assessment workflows into the clinical environment. This enables cognitive insights to flow into everyday care within the most widely adopted EHR system used by 42% of large healthcare organizations.
Western UniversitycoreStrategic or Co-development Partner · 8 April 2026Researchers at Western University conducted a peer-reviewed validation study published in the Journal of Alzheimer's Disease, demonstrating Creyos' digital screener achieves 100% sensitivity and 86% specificity for Alzheimer's detection. The study validates Creyos as a faster, more sensitive approach to dementia detection in primary care.
AARPmajorStrategic or Co-development Partner · 1 January 2020AARP chose Cambridge Brain Sciences (now Creyos) to deliver their Staying Sharp Program, focused on cognitive health for older adults.
AthenahealthcoreTechnology or IntegrationCreyos integrates with Athenahealth EHR for seamless cognitive care through automated reporting, results interpretation, and workflow integration.

Scale indicators5 records

Recent moves6 records

Creyos competitors and assessment

Company assessment

Direct peers

Linus Health: Linus Health offers digital cognitive assessment (e.g., DCTclock, Linus Brain Health Platform) for early detection of Alzheimer's and other dementias, directly competing with Creyos in primary care dementia screening with similar EHR integration strategy.
BrainCheck: BrainCheck provides digital cognitive assessment batteries and concussion screening tools used by clinicians across neurology, primary care, and sports medicine, overlapping directly with Creyos's 12-task battery and concussion clinic segments.
Cambridge Cognition: Cambridge Cognition offers computerized cognitive testing (CANTAB) for clinical trials and healthcare, sharing scientific heritage with Creyos and competing in the same neurological/psychiatric assessment space.
Cogstate: Cogstate provides digital cognitive assessment for clinical trials, healthcare, and concussion management, with comparable FDA-cleared tools and a similar customer base in pharma research and sports medicine.
Neurotrack: Neurotrack develops digital cognitive screening and brain health tools for early Alzheimer's detection, directly competing with Creyos's two-task screener in the primary care and consumer brain-health segments.
CNS Vital Signs: CNS Vital Signs provides computerized neurocognitive testing batteries for clinicians, researchers, and concussion programs, with comparable product offering and target segments to Creyos.

Emerging players

Altoida: Altoida uses AI-driven digital cognitive assessment (including AR-based tasks) to predict and detect cognitive impairment, representing an emerging technology approach that overlaps with Creyos's machine-learning-based screener.
Savonix: Savonix offers a digital cognitive assessment platform for clinicians and payers, with a similar mobile-first assessment model targeting dementia screening and behavioral health.
Total Brain: Total Brain delivers web-based cognitive and emotional self-assessment tools for healthcare and consumer wellness, with overlapping mental health and brain-health screening use cases versus Creyos.

Broad incumbents

Headspace Health (Ginger): Headspace Health (including the Ginger acquisition) offers broad mental health assessment and behavioral health screening at scale, partially overlapping with Creyos's behavioral health questionnaire suite in employer/payer channels.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Creyos compliance and trust

Trust signal

Compliance1 record

Creyos financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Creyos leadership team

Management profile

Number of profiles

Profiles12 records

Creyos funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Creyos M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Creyos

What does Creyos do?

Is Creyos a public or private company?

Creyos is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Creyos founded?

Creyos was founded in 2014. It employs 51 to 100 people.

Where is Creyos based?

Creyos is headquartered in Toronto, Canada, in the North America region.

How does Creyos make money?

One revenue line is on record: cognitive Assessment Platform Subscription.

Who are Creyos's main competitors?

Direct peers on record are Linus Health, BrainCheck, Cambridge Cognition, Cogstate, Neurotrack and CNS Vital Signs. Emerging players are Altoida, Savonix and Total Brain. Headspace Health (Ginger) is listed as a broad incumbent.

Does Creyos have an API?

Yes. Creyos offers an API that enables cognitive assessment workflows to be embedded into clinical environments. The platform integrates with Epic EHR systems, allowing cognitive assessment data to flow directly into patient records within existing clinical workflows. Developer documentation is at cambridgebrainsciences.zendesk.com/hc/en-us.

What industry is Creyos in?

Creyos's product category is Digital Cognitive Assessment Software. Its primary akta.pro industry code is HLACAEAO, Patient Relationship Management (PRM) & CRM for Provider Growth (Marketing/Outreach). Its NAICS code is 5182 and its SIC code is 7372.